Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M July 11, 2022 Diabetes Research diabetesknow
Breakthroughs in Pancreatic Cell Replacement: ViaCyte Interview May 5, 2021 Diabetes Research diabetesknow